The U.S. Department of Defense has inflicted substantial reputational, commercial, and operational damage to the China-headquartered CRDMO, according to its lawsuit.
The Bohumil site will initially produce supportive proteins for next-generation diabetes and obesity medicines as part of Novo Nordisk’s global manufacturing network.
The inspection supported EU marketing authorization applications for 19 biologics spanning antibodies, enzymes and fusion proteins from 13 clients, according to company.
Go beyond similarity in this webchat with a Thermo Fisher Scientific expert on how a p-value-based multivariate residual approach verifies pharmaceutical raw materials.
